Drug & intervention
mirtazapine 15 MG Disintegrating Oral Tablet [Remeron]
RxCUI 752869
What this record represents
SBD · RxNormThis is an RxNorm SBD drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
RemeronBN · CureCurrent ID 21983
mirtazapine 15 MG [Remeron]SBDC · CureCurrent ID 35006
mirtazapine 30 MG [Remeron]SBDC · CureCurrent ID 35007
mirtazapine 45 MG [Remeron]SBDC · CureCurrent ID 35224
mirtazapine Oral Tablet [Remeron]SBDF · CureCurrent ID 30626
mirtazapine 15 MG Oral Tablet [Remeron]SBD · CureCurrent ID 23866
mirtazapine 30 MG Oral Tablet [Remeron]SBD · CureCurrent ID 23867
mirtazapine Disintegrating Oral Tablet [Remeron]SBDF · CureCurrent ID 38531
mirtazapine 30 MG Disintegrating Oral Tablet [Remeron]SBD · CureCurrent ID 38533
mirtazapine 45 MG Disintegrating Oral Tablet [Remeron]SBD · CureCurrent ID 38534
Molecular structure
Active ingredient: mirtazapineAdvertisement
Active ingredients and chemical structures
RxNorm ingredient relationships. Structures are retrieved by PubChem compound identifier when available. An ingredient can have both a base and a precise salt concept.
Conditions being studied
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.